 |
Big Pharma Gets a Booster Shot May 31, 2006 18:33
|
S & P Pharma analyst believes the large pharmaceutical sales companies are bouncing back from a rough previous year that included a large number of patents expiring, hard-core litigation against their blockbusters, and the resulting generics bonanza. However, despite concerns over pricing and patent expirations, S&P thinks pharmaceuticals remains one of the healthiest and widest-margin U.S. industries.
For more information, click on the "cool link", below!
Cool Link
|
Pharmaceutical Sales Interview Coaching-News Blog Home
Archives
Articles
July 2006 June 2006 May 2006 April 2006 March 2006 February 2006 January 2006 December 2005 November 2005
RSS Feed For This News
|